基于造影的径向壁应变对非限流性冠状动脉狭窄的短期风险分层
该研究为FAVOR III China试验的事后分析,纳入751例患者共824条非限流性血管,评估造影衍生的径向壁应变(RWS)对1年血管导向复合终点(VOCE)的预测价值。结果显示RWSmax>12%是VOCE的强独立预测因子(校正HR 4.44),联合μQFR可进一步降低延期血运重建风险。
要点
- RWSmax>12%的血管1年VOCE发生率为14.3%,显著高于≤12%者的2.9%。
- RWSmax>12%是非限流性血管1年VOCE的独立预测因子(校正HR 4.44)。
- 联合正常RWSmax与μQFR较单用μQFR可降低延期血运重建风险(校正HR 0.52)。
核心结论
- 在冠脉血流保留的血管中,造影衍生的RWS分析可进一步区分1年VOCE风险较高的血管。
研究设计与样本
- FAVOR III China试验的事后分析,纳入751例患者共824条非限流性血管,每条血管至少1处轻度狭窄病变。
主要发现
- 1年随访期间,824条血管中46条发生VOCE,累积发生率为5.6%。
- RWSmax预测1年VOCE的曲线下面积为0.68(95%CI 0.58-0.77;P<0.001)。
- RWSmax>12%的血管VOCE发生率为14.3%,RWSmax≤12%者为2.9%。
- 多变量Cox回归中,RWSmax>12%是延期非限流性血管1年VOCE的强独立预测因子(校正HR 4.44;95%CI 2.43-8.14;P<0.001)。
- 联合正常RWSmax与μQFR较单用μQFR的延期血运重建风险显著降低(校正HR 0.52;95%CI 0.30-0.90;P=0.019)。
关键数值与推荐
- RWSmax>12%作为风险分层阈值,对应1年VOCE发生率14.3% vs 2.9%。
- RWSmax预测1年VOCE的AUC为0.68(95%CI 0.58-0.77;P<0.001)。
- RWSmax>12%的校正HR为4.44(95%CI 2.43-8.14;P<0.001)。
- 联合正常RWSmax与μQFR的校正HR为0.52(95%CI 0.30-0.90;P=0.019)。
临床怎么用
- 对非限流性轻度冠状动脉狭窄,可考虑计算造影衍生RWSmax辅助风险分层。
- RWSmax>12%提示1年VOCE风险较高,可优化延期血运重建决策。
- 联合RWSmax与μQFR可能较单用μQFR进一步降低延期血运重建风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deferred revascularization of mildly stenotic coronary vessels based exclusively on physiological evaluation is associated with up to 5% residual incidence of future adverse events at 1 year. OBJECTIVES: We aimed to evaluate the incremental value of angiography-derived radial wall strain (RWS) in risk stratification of non-flow-limiting mild coronary narrowings. METHODS: This is a post hoc analysis of 824 non-flow-limiting vessels in 751 patients from the FAVOR III China (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients With Coronary Artery Disease) trial. Each individual vessel had ≥1 mildly stenotic lesion. The primary outcome was vessel-oriented composite endpoint (VOCE), defined as the composite of vessel-related cardiac death, vessel-related myocardial infarction (nonprocedural), and ischemia-driven target vessel revascularization at 1-year follow-up. RESULTS: During 1-year follow-up, VOCE occurred in 46 of 824 vessels, with a cumulative incidence of 5.6%. Maximum RWS (RWSmax) was predictive of 1-year VOCE with an area under the curve of 0.68 (95% CI: 0.58-0.77; P < 0.001). The incidence of VOCE was 14.3% in vessels with RWSmax >12% vs 2.9% in those with RWSmax ≤12%. In the multivariable Cox regression model, RWSmax >12% was a strong independent predictor of 1-year VOCE in deferred non-flow-limiting vessels (adjusted HR: 4.44; 95% CI: 2.43-8.14; P < 0.001). The risk of deferred revascularization based on combined normal RWSmax and Murray-law-based quantitative flow ratio (μQFR) was significantly reduced compared with μQFR alone (adjusted HR: 0.52; 95% CI: 0.30-0.90; P = 0.019). CONCLUSIONS: Among vessels with preserved coronary flow, angiography-derived RWS analysis has the potential to further discriminate vessels at risk of 1-year VOCE. (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients With Coronary Artery Disease [FAVOR III China Study]; NCT03656848).
引用
- Tu S, Xu B, Chen L, et al. Short-Term Risk Stratification of Non-Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain. J Am Coll Cardiol. 2023. PMID: 36813375. doi:10.1016/j.jacc.2022.11.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。